留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

心肌细胞来源NCoR1对小鼠心肌梗死损伤的保护作用

秦子涵 陈颖敏 卜军

秦子涵, 陈颖敏, 卜军. 心肌细胞来源NCoR1对小鼠心肌梗死损伤的保护作用[J]. 中华全科医学, 2021, 19(10): 1621-1625,1653. doi: 10.16766/j.cnki.issn.1674-4152.002126
引用本文: 秦子涵, 陈颖敏, 卜军. 心肌细胞来源NCoR1对小鼠心肌梗死损伤的保护作用[J]. 中华全科医学, 2021, 19(10): 1621-1625,1653. doi: 10.16766/j.cnki.issn.1674-4152.002126
QIN Zi-han, CHEN Ying-min, PU Jun. Nuclear receptor corepressor 1 significantly attenuates myocardial infarction injury in mice[J]. Chinese Journal of General Practice, 2021, 19(10): 1621-1625,1653. doi: 10.16766/j.cnki.issn.1674-4152.002126
Citation: QIN Zi-han, CHEN Ying-min, PU Jun. Nuclear receptor corepressor 1 significantly attenuates myocardial infarction injury in mice[J]. Chinese Journal of General Practice, 2021, 19(10): 1621-1625,1653. doi: 10.16766/j.cnki.issn.1674-4152.002126

心肌细胞来源NCoR1对小鼠心肌梗死损伤的保护作用

doi: 10.16766/j.cnki.issn.1674-4152.002126
基金项目: 

国家自然科学基金项目 81930007

详细信息
    通讯作者:

    卜军, E-mail: pujun310@hotmail.com

  • 中图分类号: R542.22  R-332

Nuclear receptor corepressor 1 significantly attenuates myocardial infarction injury in mice

  • 摘要:   目的  探究心肌细胞来源的核受体辅抑制因子1(NCoR1)对小鼠心肌梗死损伤发挥的作用。  方法  构建心肌细胞NCoR1特异性敲除小鼠并根据不同手术处理分为假手术野生型组、假手术基因敲除组、心肌梗死野生型组和心肌梗死基因敲除组,每组各50只小鼠。统计各组小鼠在心肌梗死28 d的生存率和心功能水平;通过病理染色判断梗死面积与纤维化程度;测定小鼠血清心肌酶[磷酸肌酸激酶(CK-MB)、乳酸脱氢酶(LDH)]及炎症指标[肿瘤坏死因子α(TNF-α)、白介素6(IL-6)]水平。  结果  与野生型小鼠相比,基因敲除组小鼠存活率更低,左心室射血分数[(30.39±5.13)% vs. (9.46±2.10)%]和左心室缩短分数[(14.62±2.69)% vs. (4.26±0.96)%]均明显下降,而左室容积[(101.50±14.07)μL vs. (197.50±22.41)μL]明显升高(均P<0.05);小动物PET/CT提示心肌梗死后野生型小鼠对18F-FDG的摄取量更高[(2.74±0.06)MBq vs. (1.60±0.03)MBq],梗死程度[(36.22±0.86)% vs. (47.17±1.27)%]和纤维化程度[(32.70±0.85)% vs. (46.38±1.31)%]更低(均P<0.05);血清学指标显示敲除小鼠心肌损伤更重且炎症水平更高(均P<0.05)。  结论  心肌细胞中NCoR1在小鼠心肌梗死中发挥重要的保护作用。

     

  • 图  1  各组小鼠心肌梗死后28 d生存率统计

    图  2  各组小鼠心肌梗死后28 d超声心动图和小动物PET/CT

    注:A为Sham-WTαMHC-Cre组;B为Sham-NCoR1Fl/Fl, αMHC-Cre组;C为MI-WTαMHC-Cre组;D为MI-NCoR1Fl/Fl, αMHC-Cre组。

    图  3  各组小鼠心脏

    注:A为Sham-WTαMHC-Cre组;B为Sham-NCoR1Fl/Fl, αMHC-Cre组;C为MI-WTαMHC-Cre组;D为MI-NCoR1Fl/Fl, αMHC-Cre组。

    图  4  各组小鼠心肌组织

    注:A为Sham-WTαMHC-Cre组;B为Sham-NCoR1Fl/Fl, αMHC-Cre组;C为MI-WTαMHC-Cre组;D为MI-NCoR1Fl/Fl, αMHC-Cre组;各组图中第2幅图为使用Masson染色,×200;第3幅图为使用天狼星红染色,×200。

    表  1  4组小鼠心功能指标结果比较(x ±s)

    组别 例数 18F-FDG摄取(MBq) LVEF(%) LVFS(%) LV容积(μL)
    假手术野生型组 10 3.64±0.04 54.07±1.05 27.48±0.66 58.09±2.01
    假手术基因敲除组 10 3.61±0.03 53.65±1.21 27.23±0.78 66.51±2.82
    心肌梗死野生型组 10 2.74±0.06a 30.39±5.13a 14.62±2.69a 101.50±14.07a
    心肌梗死基因敲除组 10 1.60±0.03bc 9.46±2.10bc 4.26±0.96bc 197.50±22.41bc
    F 5 271.000 548.940 542.860 229.300
    P <0.001 0.017 0.020 <0.001
    注:与假手术野生型组比较,aP<0.05;与假手术基因敲除组比较,bP<0.05;与心肌梗死野生型组比较,cP<0.05。
    下载: 导出CSV

    表  2  4组小鼠心肌梗死面积与纤维化程度比较(x ±s,%)

    组别 例数 梗死程度 纤维化程度
    假手术野生型组 4 0 0
    假手术基因敲除组 4 0 0
    心肌梗死野生型组 4 36.22±0.86a 32.70±0.85a
    心肌梗死基因敲除组 4 47.17±1.27bc 46.38±1.31bc
    t 14.278 17.520
    P <0.001 <0.001
    注:与假手术野生型组比较,aP<0.05;与假手术基因敲除组比较,bP<0.05;与心肌梗死野生型组比较,cP<0.05。
    下载: 导出CSV

    表  3  4组小鼠心肌标志物和炎症指标结果比较(x ±s)

    组别 例数 磷酸肌酸激酶(IU/L) 乳酸脱氢酶(IU/L) TNF-α(pg/mL) IL-6(pg/mL)
    假手术野生型组 10 188.97±22.05 201.25±45.24 2.34±0.15 2.69±0.34
    假手术基因敲除组 10 189.16±28.26 251.76±36.78 2.56±0.26 2.17±0.29
    心肌梗死野生型组 10 315.26±69.26a 320.21±85.71a 4.19±1.09a 2.99±0.52a
    心肌梗死基因敲除组 10 463.15±110.65bc 390.25±103.45bc 5.06±1.27bc 4.05±0.89bc
    F 30.660 12.620 23.670 19.910
    P 0.034 0.019 0.027 0.022
    注:与假手术野生型组比较,aP<0.05;与假手术基因敲除组比较,bP<0.05;与心肌梗死野生型组比较,cP<0.05。
    下载: 导出CSV
  • [1] DAVIDSON S M, FERDINANDY P, ANDREADOU I, et al. Multitarget strategies to reduce myocardial ischemia/reperfusion injury: Jacc review topic of the week[J]. J Am Coll Cardiol, 2019, 73(1): 89-99. doi: 10.1016/j.jacc.2018.09.086
    [2] HE Q, PU J, YUAN A, et al. Activation of liver-x-receptor alpha but not liver-x-receptor beta protects against myocardial ischemia/reperfusion injury[J]. Circ Heart Fail, 2014, 7(6): 1032-1041. doi: 10.1161/CIRCHEARTFAILURE.114.001260
    [3] HE B, ZHAO Y, XU L, et al. The nuclear melatonin receptor RORα is a novel endogenous defender against myocardial ischemia/reperfusion injury[J]. J Pineal Res, 2016, 60(3): 313-326. doi: 10.1111/jpi.12312
    [4] VEGA R B, KELLY D P. Cardiac nuclear receptors: Architects of mitochondrial structure and function[J]. J Clin Invest, 2017, 127(4): 1155-1164. doi: 10.1172/JCI88888
    [5] WAN X, LIU L, ZHOU P, et al. The nuclear receptor corepressor NCoR1 regulates hematopoiesis and leukemogenesis in vivo[J]. Blood Adv, 2019, 3(4): 644-657. doi: 10.1182/bloodadvances.2018022756
    [6] SAITO T, KUMA A, SUGIURA Y, et al. Autophagy regulates lipid metabolism through selective turnover of NCoR1[J]. Nat Commun, 2019, 10(1): 1567. doi: 10.1038/s41467-019-08829-3
    [7] MULLER L, HAINBERGER D, STOLZ V, et al. NCOR1-a new player on the field of T cell development[J]. J Leukoc Biol, 2018, 104(6): 1061-1068. doi: 10.1002/JLB.1RI0418-168R
    [8] HAINBERGER D, STOLZ V, ZHU C, et al. NCOR1 orchestrates transcriptional landscapes and effector functions of CD4(+) T cells[J]. Front Immunol, 2020, 11: 579. doi: 10.3389/fimmu.2020.00579
    [9] FU Y, JIANG W, ZHAO Y, et al. A simple and efficient method for in vivo cardiac-specific gene manipulation by intramyocardial injection in mice[J]. J Vis Exp, 2018, 16(134): 57074. http://www.onacademic.com/detail/journal_1000040287367810_0a96.html
    [10] 陈伟伟, 郑哲, 杨跃进, 等. 《中国心血管病报告2018》概要[J]. 中国循环杂志, 2019, 34(3): 209-220. doi: 10.3969/j.issn.1000-3614.2019.03.001
    [11] 郭国锋, 宋代富, 高嘉鑫, 等. 急性心肌梗死后心脏破裂的发生机制及危险因素[J]. 中华全科医学, 2019, 17(5), 829-833. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY201905034.htm
    [12] HINTON W, MCGOVERN A, COYLE R, et al. Incidence and prevalence of cardiovascular disease in english primary care: A cross-sectional and follow-up study of the royal college of general practitioners (rcgp) research and surveillance centre (rsc)[J]. BMJ Open, 2018, 8(8): e020282. doi: 10.1136/bmjopen-2017-020282
    [13] SHIMIZU H, ASTAPOVA I, YE F, et al. NcoR1 and SMRT play unique roles in thyroid hormone action in vivo[J]. Mol Cell Biol, 2015, 35(3): 555-565. doi: 10.1128/MCB.01208-14
    [14] LAZAR M A. Maturing of the nuclear receptor family[J]. J Clin Invest, 2017, 127(4): 1123-1125. doi: 10.1172/JCI92949
    [15] OU-YANG Q, LIN X M, ZHU Y J, et al. Distinct role of nuclear receptor corepressor 1 regulated de novo fatty acids synthesis in liver regeneration and hepatocarcinogenesis in mice[J]. Hepatology, 2018, 67(3): 1071-1087. doi: 10.1002/hep.29562
    [16] AHAD A, STEVANIN M, SMITA S, et al. NCoR1: Putting the brakes on the dendritic cell immune tolerance[J]. iScience, 2019, 19: 996-1011. doi: 10.1016/j.isci.2019.08.024
    [17] MULLER L, HAINBERGER D, STOLZ V, et al. The corepressor ncor1 regulates the survival of single-positive thymocytes[J]. Sci Rep, 2017, 7(1): 15928. doi: 10.1038/s41598-017-15918-0
    [18] MENNILLO E, YANG X, PASZEK M, et al. NCoR1 protects mice from dextran sodium sulfate-induced colitis by guarding colonic crypt cells from luminal insult[J]. Cell Mol Gastroenterol Hepatol, 2020, 10(1): 133-147. doi: 10.1016/j.jcmgh.2020.01.014
    [19] CHEN N D, JIAN H, FANG N, et al. Intramuscular accumulation of pentadecanoic acid activates AKT1 to phosphorylate NCOR1 and triggers FOXM1-mediated apoptosis in the pathogenesis of sarcopenia[J]. Am J Transl Res, 2020, 15(12): 5064-5079. http://www.researchgate.net/publication/346260811_Intramuscular_accumulation_of_pentadecanoic_acid_activates_AKT1_to_phosphorylate_NCOR1_and_triggers_FOXM1-mediated_apoptosis_in_the_pathogenesis_of_sarcopenia
    [20] LI C, SUN X N, CHEN B Y, et al. Nuclear receptor corepressor 1 represses cardiac hypertrophy[J]. EMBO Mol Med, 2019, 11(11): e9127. http://www.sciencedirect.com/science/article/pii/S073510978580111X/pdf?md5=19d9540a9cd199c9f0050076f38e9834&pid=1-s2.0-S073510978580111X-main.pdf
    [21] PFLUGER-MULLER B, OO J A, HEERING J, et al. The endocannabinoid anandamide has an anti-inflammatory effect on CCL2 expression in vascular smooth muscle cells[J]. Basic Res Cardiol, 2020, 115(3): 34. doi: 10.1007/s00395-020-0793-3
    [22] OPPI S, NUSSER-STEIN S, BLYSZCZUK P, et al. Macrophage NCOR1 protects from atherosclerosis by repressing a pro-atherogenic PPARγ signature[J]. Eur Heart J, 2020, 41(9): 995-1005. http://www.researchgate.net/publication/335921306_Macrophage_NCOR1_protects_from_atherosclerosis_by_repressing_a_pro-atherogenic_PPARg_signature
  • 加载中
图(4) / 表(3)
计量
  • 文章访问数:  100
  • HTML全文浏览量:  53
  • PDF下载量:  1
  • 被引次数: 0
出版历程
  • 收稿日期:  2021-01-28
  • 网络出版日期:  2022-02-15

目录

    /

    返回文章
    返回